International Journal of Medical Investigation
Int J Med Invest
Medical Sciences
http://intjmi.com
1
admin
2322-2913
2345-640x
no
no
14
8888
13
en
jalali
1394
3
1
gregorian
2015
6
1
4
2
online
1
fulltext
en
Assessment the clinical and paraclinical effects of enhanced external counter pulsation therapy in patients with coronary artery disease
عمومى
General
پژوهشي
Research
Background: the aim of this study was assessment the clinical and paraclinical effects of enhanced external counter pulsation (EECP) therapy in patients with coronary artery disease. Patients and Methods: We performed a retrospective analysis of data related to all patients who received EECP treatment at Shafa hospitals in Sari, Iran from 21 March 2013 to 21 March 2015. All patient’s data included demographic data, history of underlying disease, clinical sign and symptom, laboratory data (hemoglobin, triglyceride (TG), cholesterol, Low-density lipoprotein (LDL), High-density lipoprotein (HDL)) and left ventricular ejection fraction (LVEF) in before and after treatment by EECP were collected. Results: the data of 48 patients (include 25 men) with mean age of 62.20±10.15 years were collected. The mean of TG, Cholesterol, LDL and HDL were not significantly change after EECP therapy. However, the mean of hemoglobin (10.47±0.81mg/dl vs. 10.20±1.03mg/dl, P=0.019) and LVEF (40.10±5.40% vs. 36.04±5.64%, P<0.0001) were significantly increased after EECP therapy. Also, the mean of systolic (112.81±6.75mmHg vs. 124.27±9.56mmHg, P<0.0001) and diastolic (71.35±5.90mmHg vs. 75.52±5.38mmHg, P<0.0001) blood pressure were significantly decrease after treatment with EECP. Clinical improvement of chest pain, muscle weakness, dyspnea and daily activity were observed in 14 patients (29.2%), 11 patients (22.9%), 24 patients (50%) and 28 patients (58.3%), respectively. Finally 31 patients (64.6%) were satisfy form this treatment. The complication included low back pain in 6 patients (12.5%) and paresthesia in 4 patients (8.3%). Conclusion: In conclusion, the results of our study show EECP therapy is a safe treatment and can reduced systolic and diastolic blood pressure, increase hemoglobin level and LVEF and improve clinical condition of CAD patients.
coronary artery disease, enhanced external counter pulsation, left ventricular ejection fraction, clinical parameters, paraclinical parameters
245
248
http://intjmi.com/browse.php?a_code=A-10-1-86&slc_lang=en&sid=1
Shervin
ziabakhsh Tabary
10031947532846002458
10031947532846002458
No
Cardiac surgery department, Fatemeh Zahra hospital of Sari, Mazandaran University of Medical Sciences, Sari, Iran
Keyvan
Yousefnejad
10031947532846002459
10031947532846002459
No
Department of Cardiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
Taraneh
Ziaee
10031947532846002460
10031947532846002460
No
Faculty of Medicine, Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran
Mehran
Fazli
10031947532846002461
10031947532846002461
Yes
General Practitioner in Imam Khomeini Hospital of Esfarayen, Esfarayen Faculty of Medical Sciences, Esfarayen, Iran